查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1760650

下一代腫瘤設備和解決方案全球市場報告（2025年）

Next-Generation Oncology Devices And Solutions Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年，下一代腫瘤設備和解決方案市場規模將快速成長。到2029年，該市場規模將達到327.3億美元，複合年成長率為18.6%。預測期內，預期成長將受到以下因素的推動：全球人口老化、腫瘤新興企業投資增加、醫療成本上漲、對非侵入性或微創診斷的需求成長以及醫療基礎設施的不斷發展。預測期內的主要趨勢包括人工智慧輔助診斷影像、液態切片的進步、個人化醫療平台、穿戴式健康監測設備、機器人技術和微創手術工具。

癌症發生率的上升預計將推動下一代腫瘤設備和解決方案市場的擴張。癌症是一種以異常細胞不受控制地生長為特徵的疾病，異常細胞會擴散到身體的其他部位並破壞正常功能。癌症發生率的上升主要是由於人口老化，因為罹患癌症的風險隨著年齡的成長而增加。下一代腫瘤設備和解決方案透過實現更早的發現、更準確的診斷和個人化治療來幫助應對這一成長。例如，美國非營利組織美國癌症協會估計，到 2024 年 1 月，美國癌症死亡人數將超過 611,000 人，相當於每天超過 1,600 人死亡。因此，癌症發生率的上升是下一代腫瘤設備和解決方案市場成長的主要驅動力。

新一代腫瘤設備和解決方案市場的主要企業正專注於技術創新，例如次世代定序儀(NGS) 標靶富集解決方案，以改善對罕見基因突變的檢測，提高定序準確性，並加速癌症診斷和治療決策。 NGS 標靶富集解決方案是一種選擇性捕獲和富集特定 DNA 或 RNA 區域的技術，可更準確、更有效地分析與癌症和其他疾病相關的基因突變。例如，2025 年 4 月，美國生物技術公司 Integrated DNA Technologies (IDT) 推出了 xGen Hybridization and Wash v3 試劑盒，這是一款先進的雜合反應捕獲解決方案，旨在透過簡化 NGS 工作流程來加速癌症研究。該套件將雜合反應時間縮短至僅需一小時，使研究人員能夠在一次運行中完成從樣品製備到定序的所有過程。透過消除對加熱緩衝液的需求並將手動操作時間減少 20%，該解決方案非常適合自動化，是高通量應用的理想選擇。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場宏觀經濟情境：包括利率、通貨膨脹、地緣政治、貿易戰、關稅以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球下一代腫瘤設備和解決方案市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球下一代腫瘤設備和解決方案市場：成長率分析
  • 全球下一代腫瘤設備和解決方案市場規模和成長率：實際成果值，2019-2024 年
  • 全球下一代腫瘤設備和解決方案市場規模和成長率：預測，2024-2029 年，2034 年
  • 全球下一代腫瘤設備和解決方案市場：總可用市場（TAM）

第6章市場區隔

  • 全球下一代腫瘤設備和解決方案市場（按癌症類型、實際成果值和預測），2019-2024 年、2024-2029 年、2034 年
  • 乳癌
  • 子宮頸癌
  • 大腸直腸癌
  • 肺癌
  • 全球下一代腫瘤設備和解決方案市場（按技術、實際成果值和預測），2019-2024 年、2024-2029 年、2034 年
  • 次世代定序（NGS）
  • 聚合酵素鏈鎖反應（PCR）
  • DNA微陣列
  • 連接複用
  • 其他技術
  • 全球下一代腫瘤設備和解決方案市場的應用、實際成果值和預測值（2019-2024 年、2024-2029 年和 2034 年）
  • 篩檢和早期檢測
  • 預測和監測
  • 治療方法方案
  • 復發監測
  • 其他用途
  • 全球下一代腫瘤設備和解決方案市場按最終用途、實際成果值和預測值，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 診斷實驗室
  • 學術研究所
  • 其他最終用戶
  • 全球下一代腫瘤設備和解決方案市場（按乳癌類型、實際成果值和預測值），2019-2024 年、2024-2029 年、2034 年
  • 浸潤性乳管癌
  • 浸潤性小葉癌
  • 三陰性乳癌
  • HER2陽性乳癌
  • 全球下一代腫瘤設備和解決方案市場（按子宮頸癌類型、實際成果值和預測值），2019-2024 年、2024-2029 年、2034 年
  • 鱗狀細胞癌
  • 腺癌
  • 腺鱗癌
  • 全球下一代腫瘤設備和解決方案市場按結直腸癌類型、實際成果值和預測值，2019-2024 年、2024-2029 年、2034 年
  • 大腸直腸癌
  • 直腸癌
  • 轉移性大腸直腸癌
  • 全球下一代腫瘤設備和解決方案市場（按肺癌類型、實際成果值和預測值），2019-2024 年、2024-2029 年、2034 年
  • 非小細胞肺癌（NSCLC）
  • 小細胞肺癌（SCLC）
  • 肺腺癌
  • 鱗狀細胞肺癌

第7章 區域和國家分析

  • 全球下一代腫瘤設備和解決方案市場（按地區、實際成果值和預測）2019-2024 年、2024-2029 年、2034 年
  • 全球下一代腫瘤設備和解決方案市場（按國家/地區分類）、實際成果值和預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 下一代腫瘤設備和解決方案市場：競爭格局
  • 下一代腫瘤設備和解決方案市場：公司簡介
    • 強生服務公司（概況、產品與服務、策略、財務分析）
    • 西門子股份公司（概況、產品與服務、策略、財務分析）
    • 默克公司（概況、產品與服務、策略、財務分析）
    • 賽默飛世爾科技公司（概況、產品與服務、策略、財務分析）
    • 諾華公司（概況、產品與服務、策略、財務分析）

第31章 其他大型創新企業

  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • Agilent Technologies Inc.
  • Illumina Inc.
  • Sysmex Corporation
  • QIAGEN NV
  • Exact Sciences Corporation
  • Elekta AB
  • Myriad Genetics Inc.
  • Takara Bio USA Inc.
  • NeoGenomics Inc.
  • Guardant Health Inc.
  • Accuray Incorporated
  • SOPHiA GENETICS SA
  • Paige.AI Inc.

第 32 章全球市場：競爭基準化分析板

第33章 重大企業合併（M&A）

第34章近期市場趨勢

第35章：具有高市場潛力的國家、產業與策略

  • 下一代腫瘤設備和解決方案市場：提供新機會的國家（2029 年）
  • 下一代腫瘤設備和解決方案市場：提供新機會的產業（2029 年）
  • 下一代腫瘤設備和解決方案市場：成長策略（2029年）
    • 基於市場趨勢的策略
    • 競爭策略

第36章 附錄

簡介目錄
Product Code: r35527

Next-generation oncology devices and solutions encompass advanced technologies and tools developed to detect, diagnose, monitor, and treat various forms of cancer with enhanced precision and speed. Their goal is to facilitate personalized cancer care by utilizing innovations such as next-generation sequencing, digital pathology, and targeted therapies to improve patient outcomes.

The primary cancer types addressed by next-generation oncology devices and solutions include breast cancer, cervical cancer, colorectal cancer, and lung cancer. Breast cancer is a condition where cells in the breast grow uncontrollably, often forming a tumor that can be felt as a lump or identified through imaging. These solutions employ technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), DNA microarrays, multiplexing, and other advanced techniques, which are applied in areas such as screening and early detection, prognostics and monitoring, therapy selection, and recurrence monitoring. The key end users include hospitals and clinics, diagnostic laboratories, academic and research institutions, and more.

The next-generation oncology devices and solutions market research report is one of a series of new reports from The Business Research Company that provides next-generation oncology devices and solutions market statistics, including the next-generation oncology devices and solutions industry global market size, regional shares, competitors with the next-generation oncology devices and solutions market share, detailed next-generation oncology devices and solutions market segments, market trends, and opportunities, and any further data you may need to thrive in the next-generation oncology devices and solutions industry. This next-generation oncology devices and solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The next-generation oncology devices and solutions market size has grown rapidly in recent years. It will grow from $13.90 billion in 2024 to $16.52 billion in 2025 at a compound annual growth rate (CAGR) of 18.9%. The growth observed in the historical period can be attributed to the increasing global cancer incidence, expansion of oncology research and clinical trials, advancements in precision medicine, growth of hospital and diagnostic infrastructure, and greater awareness of early cancer screening.

The next-generation oncology devices and solutions market size is expected to see rapid growth in the next few years. It will grow to $32.73 billion in 2029 at a compound annual growth rate (CAGR) of 18.6%. The growth anticipated in the forecast period is driven by the aging global population, increased investment in oncology startups, rising healthcare expenditures, greater demand for non-invasive or minimally invasive diagnostics, and the development of healthcare infrastructures. Key trends in the forecast period include AI-powered diagnostic imaging, advancements in liquid biopsy, personalized medicine platforms, wearable health monitoring devices, robotics, and minimally invasive surgical tools.

The growing prevalence of cancer is expected to drive the expansion of the next-generation oncology devices and solutions market. Cancer is a disease characterized by uncontrolled growth of abnormal cells, which can spread to other areas of the body, disrupting normal functions. The increasing prevalence of cancer is mainly due to aging populations, as the risk of developing cancer rises with age. Next-generation oncology devices and solutions help address this rise by enabling earlier detection, more accurate diagnosis, and personalized treatment. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization, estimated that cancer would cause over 611,000 deaths in the United States, which equals more than 1,600 cancer-related deaths per day. As such, the growing prevalence of cancer is a key driver for the growth of the next-generation oncology devices and solutions market.

Leading companies in the next-generation oncology devices and solutions market are focusing on technological innovations, such as next-generation sequencing (NGS) target enrichment solutions, to improve the detection of rare genetic variants, enhance sequencing accuracy, and expedite cancer diagnosis and treatment decisions. NGS target enrichment solutions involve techniques that selectively capture and concentrate specific DNA or RNA regions for sequencing, allowing more precise and efficient analysis of genetic variants associated with cancer and other diseases. For instance, in April 2025, Integrated DNA Technologies (IDT), a US-based biotechnology company, launched the xGen Hybridization and Wash v3 Kit, an advanced hybridization capture solution designed to accelerate cancer research by streamlining NGS workflows. This kit reduces hybridization time to just one hour, enabling researchers to complete sample preparation and sequencing in a single workday. By eliminating the need for heated buffers and cutting hands-on time by 20%, the solution is highly automation-friendly and ideal for high-throughput applications.

In July 2024, Hologic, a US-based medical technology company, acquired Endomag for an undisclosed amount. This acquisition aims to enhance Hologic's breast cancer surgery portfolio by incorporating Endomag's innovative surgical guidance products, which improve the precision and effectiveness of cancer care. Endomag, a UK-based medical device manufacturer, specializes in surgical guidance products for breast cancer treatment.

Major players in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., and Lucida Medical Ltd.

North America was the largest region in the next-generation oncology devices and solutions market in 2024. The regions covered in next-generation oncology devices and solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the next-generation oncology devices and solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The next-generation oncology devices and solutions market consists of revenues earned by entities by providing services such as cancer genomic profiling and sequencing, personalized treatment planning, remote patient monitoring and tele-oncology, and early cancer detection and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation oncology devices and solutions market also includes sales of liquid biopsy kits, companion diagnostic tests, digital pathology systems, cancer biomarker detection assays, and targeted therapy monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation Oncology Devices And Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on next-generation oncology devices and solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation oncology devices and solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The next-generation oncology devices and solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Cancer Type: Breast Cancer; Cervical Cancer; Colorectal Cancer; Lung Cancer
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); DNA Microarrays; Multiplexing; Other Technologies
  • 3) By Application: Screening And Early Detection; Prognostics And Monitoring; Therapy Selection; Recurrence Monitoring; Other Applications
  • 4) By End Use: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutions; Other End Uses
  • Subsegments:
  • 1) By Breast Cancer: Invasive Ductal Carcinoma; Invasive Lobular Carcinoma; Triple-Negative Breast Cancer; HER2-Positive Breast Cancer
  • 2) By Cervical Cancer: Squamous Cell Carcinoma; Adenocarcinoma; Adenosquamous Carcinoma
  • 3) By Colorectal Cancer: Colon Cancer; Rectal Cancer; Metastatic Colorectal Cancer
  • 4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC); Small Cell Lung Cancer (SCLC); Lung Adenocarcinoma; Squamous Cell Lung Carcinoma
  • Companies Mentioned: Johnson & Johnson Services Inc.; Siemens AG; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Next-Generation Oncology Devices And Solutions Market Characteristics

3. Next-Generation Oncology Devices And Solutions Market Trends And Strategies

4. Next-Generation Oncology Devices And Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Next-Generation Oncology Devices And Solutions Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Next-Generation Oncology Devices And Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Next-Generation Oncology Devices And Solutions Market Growth Rate Analysis
  • 5.4. Global Next-Generation Oncology Devices And Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Next-Generation Oncology Devices And Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Next-Generation Oncology Devices And Solutions Total Addressable Market (TAM)

6. Next-Generation Oncology Devices And Solutions Market Segmentation

  • 6.1. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Lung Cancer
  • 6.2. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • DNA Microarrays
  • Multiplexing
  • Other Technologies
  • 6.3. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Screening And Early Detection
  • Prognostics And Monitoring
  • Therapy Selection
  • Recurrence Monitoring
  • Other Applications
  • 6.4. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic laboratories
  • Academic And Research Institutions
  • Other End Users
  • 6.5. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Breast Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Triple-Negative Breast Cancer
  • HER2-Positive Breast Cancer
  • 6.6. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Cervical Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Squamous Cell Carcinoma
  • Adenocarcinoma
  • Adenosquamous Carcinoma
  • 6.7. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Colon Cancer
  • Rectal Cancer
  • Metastatic Colorectal Cancer
  • 6.8. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Lung Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer (SCLC)
  • Lung Adenocarcinoma
  • Squamous Cell Lung Carcinoma

7. Next-Generation Oncology Devices And Solutions Market Regional And Country Analysis

  • 7.1. Global Next-Generation Oncology Devices And Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Next-Generation Oncology Devices And Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Next-Generation Oncology Devices And Solutions Market

  • 8.1. Asia-Pacific Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Next-Generation Oncology Devices And Solutions Market

  • 9.1. China Next-Generation Oncology Devices And Solutions Market Overview
  • 9.2. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Next-Generation Oncology Devices And Solutions Market

  • 10.1. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Next-Generation Oncology Devices And Solutions Market

  • 11.1. Japan Next-Generation Oncology Devices And Solutions Market Overview
  • 11.2. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Next-Generation Oncology Devices And Solutions Market

  • 12.1. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Next-Generation Oncology Devices And Solutions Market

  • 13.1. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Next-Generation Oncology Devices And Solutions Market

  • 14.1. South Korea Next-Generation Oncology Devices And Solutions Market Overview
  • 14.2. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Next-Generation Oncology Devices And Solutions Market

  • 15.1. Western Europe Next-Generation Oncology Devices And Solutions Market Overview
  • 15.2. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Next-Generation Oncology Devices And Solutions Market

  • 16.1. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Next-Generation Oncology Devices And Solutions Market

  • 17.1. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Next-Generation Oncology Devices And Solutions Market

  • 18.1. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Next-Generation Oncology Devices And Solutions Market

  • 19.1. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Next-Generation Oncology Devices And Solutions Market

  • 20.1. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Next-Generation Oncology Devices And Solutions Market

  • 21.1. Eastern Europe Next-Generation Oncology Devices And Solutions Market Overview
  • 21.2. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Next-Generation Oncology Devices And Solutions Market

  • 22.1. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Next-Generation Oncology Devices And Solutions Market

  • 23.1. North America Next-Generation Oncology Devices And Solutions Market Overview
  • 23.2. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Next-Generation Oncology Devices And Solutions Market

  • 24.1. USA Next-Generation Oncology Devices And Solutions Market Overview
  • 24.2. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Next-Generation Oncology Devices And Solutions Market

  • 25.1. Canada Next-Generation Oncology Devices And Solutions Market Overview
  • 25.2. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Next-Generation Oncology Devices And Solutions Market

  • 26.1. South America Next-Generation Oncology Devices And Solutions Market Overview
  • 26.2. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Next-Generation Oncology Devices And Solutions Market

  • 27.1. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Next-Generation Oncology Devices And Solutions Market

  • 28.1. Middle East Next-Generation Oncology Devices And Solutions Market Overview
  • 28.2. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Next-Generation Oncology Devices And Solutions Market

  • 29.1. Africa Next-Generation Oncology Devices And Solutions Market Overview
  • 29.2. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Next-Generation Oncology Devices And Solutions Market Competitive Landscape And Company Profiles

  • 30.1. Next-Generation Oncology Devices And Solutions Market Competitive Landscape
  • 30.2. Next-Generation Oncology Devices And Solutions Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Next-Generation Oncology Devices And Solutions Market Other Major And Innovative Companies

  • 31.1. Koninklijke Philips N.V.
  • 31.2. GE HealthCare Technologies Inc.
  • 31.3. Agilent Technologies Inc.
  • 31.4. Illumina Inc.
  • 31.5. Sysmex Corporation
  • 31.6. QIAGEN N.V.
  • 31.7. Exact Sciences Corporation
  • 31.8. Elekta AB
  • 31.9. Myriad Genetics Inc.
  • 31.10. Takara Bio USA Inc.
  • 31.11. NeoGenomics Inc.
  • 31.12. Guardant Health Inc.
  • 31.13. Accuray Incorporated
  • 31.14. SOPHiA GENETICS SA
  • 31.15. Paige.AI Inc.

32. Global Next-Generation Oncology Devices And Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Next-Generation Oncology Devices And Solutions Market

34. Recent Developments In The Next-Generation Oncology Devices And Solutions Market

35. Next-Generation Oncology Devices And Solutions Market High Potential Countries, Segments and Strategies

  • 35.1 Next-Generation Oncology Devices And Solutions Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Next-Generation Oncology Devices And Solutions Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Next-Generation Oncology Devices And Solutions Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer